The first Angiodynamic trade was made in Q4 2010.
Since then Joel Greenblatt bought shares ten more times and sold shares on nine occasions. The investor sold all their shares in Q3 2021 and doesn't own any shares in Angiodynamic anymore.
Avg closing price
Price range
Sold -10.9 Thousand shares
Q3 2021
Avg closing price
$26.74
Price range
$23.36
-
$29.20
New holding (+10.9 Thousand shares)
Q2 2021
Avg closing price
$24.42
Price range
$22.39
-
$28.07
Sold -27.7 Thousand shares
Q1 2018
Avg closing price
$16.68
Price range
$15.71
-
$17.70
Sold 43.7% shares (-21.5 Thousand shares)
Q4 2017
Avg closing price
$17.06
Price range
$16.56
-
$17.80
Sold 37.7% shares (-29.8 Thousand shares)
Q3 2017
Avg closing price
$16.80
Price range
$15.12
-
$18.76
Increased shares by 44.0% (+24.1 Thousand shares)
Q2 2017
Avg closing price
$15.81
Price range
$15.08
-
$17.20
Sold 10.2% shares (-6.26 Thousand shares)
Q1 2017
Avg closing price
$16.72
Price range
$15.89
-
$17.81
Increased shares by 6.6% (+3.77 Thousand shares)
Q4 2016
Avg closing price
$16.68
Price range
$15.40
-
$17.43
Increased shares by 286.4% (+42.5 Thousand shares)
Q3 2016
Avg closing price
$16.22
Price range
$13.84
-
$17.54
New holding (+14.8 Thousand shares)
Q2 2016
Avg closing price
$12.50
Price range
$10.78
-
$14.37
Sold -16 Thousand shares
Q4 2013
Avg closing price
$15.39
Price range
$13.38
-
$17.16
New holding (+16 Thousand shares)
Q3 2013
Avg closing price
$11.78
Price range
$10.90
-
$13.55
Sold -1.61 Thousand shares
Q3 2012
Avg closing price
$11.43
Price range
$10.41
-
$12.66
Sold 6.5% shares (-112 shares)
Q2 2012
Avg closing price
$12.15
Price range
$11.61
-
$12.49
Increased shares by 56.5% (+620 shares)
Q1 2012
Avg closing price
$13.10
Price range
$12.22
-
$14.82
Increased shares by 30.9% (+259 shares)
Q4 2011
Avg closing price
$14.72
Price range
$13.00
-
$16.16
Increased shares by 46.2% (+265 shares)
Q3 2011
Avg closing price
$13.92
Price range
$12.81
-
$15.44
Sold 98.5% shares (-38.7 Thousand shares)
Q2 2011
Avg closing price
$15.12
Price range
$13.06
-
$16.55
Increased shares by 169.3% (+24.7 Thousand shares)
Q1 2011